Gut · 2026-06-26
IDDF2026-ABS-0342 Clinical outcomes associated with GLP-1 receptor agonists in patients with chronic pancreatitis and type 2 diabetes mellitus: a real world cohort study
Phrase rank #2 · DOI 10.1136/gutjnl-2026-IDDF.324
Other observed topics
receptor
Observed in 53 articles across 21 journals.
Latest share0.13%
Change vs baseline+0.05 pp
Months observed12
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer12
- BMJ Open Diabetes Research & Care4
- Gut4
- BMJ3
- BMJ Supportive & Palliative Care3
- Heart3
- Lupus Science & Medicine3
- RMD Open3
- BMJ Case Reports2
- Journal of Neurology, Neurosurgery & Psychiatry2
- Journal of Scleroderma and Related Disorders2
- Practical Neurology2
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
RMD Open · 2025-09-23
If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?
Phrase rank #3 · DOI 10.1136/rmdopen-2025-006025
Lupus Science & Medicine · 2026-07-01
Anti-endothelin receptor A autoantibodies associate with immunovascular risk and activate endothelial signalling in SLE
Phrase rank #4 · DOI 10.1136/lupus-2026-002117
BMJ Neurology Open · 2025-12-21
Cardiac involvement in anti-GABA-B receptor encephalitis: a case report
Phrase rank #4 · DOI 10.1136/bmjno-2025-001362
BMJ · 2025-08-04
Side effects of GLP-1 receptor agonists
Phrase rank #4 · DOI 10.1136/bmj.r1606
Heart · 2026-06-09
56 Adherence to NICE guidance for GLP-1 receptor agonist prescribing in patients with severe aortic stenosis and elevated body mass index
Phrase rank #5 · DOI 10.1136/heartjnl-2026-BCS.6
BMJ Supportive & Palliative Care · 2026-05-26
S1-4 Buprenorphine and methadone in the treatment of cancer pain
Phrase rank #5 · DOI 10.1136/spcare-2026-SCPSC.4
Journal for ImmunoTherapy of Cancer · 2025-11-04
799 Dissecting the role of folate receptor beta-mediated one-carbon metabolism in tumor-associated macrophages
Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.0799
Regional Anesthesia & Pain Medicine · 2025-09-10
FT40 Role of oxytocin
Phrase rank #6 · DOI 10.1136/rapm-2025-ESRA.658
Journal of Clinical Pathology · 2026-07-17
Triple-negative breast cancer: a threshold-defined diagnostic category within a biological continuum
Phrase rank #7 · DOI 10.1136/jcp-2026-210723
Practical Neurology · 2026-02-13
Anti-GABA-AR encephalitis or neuropsychiatric SLE? Avoiding misdiagnosis through comprehensive antibody testing beyond commercial panels
Phrase rank #7 · DOI 10.1136/pn-2025-004974
Thorax · 2025-11-02
S122 Oestrogen and ER-β: implications for COPD
Phrase rank #7 · DOI 10.1136/thorax-2025-BTSabstracts.128
BMJ · 2025-08-18
Correction for vol. 390, p.
Phrase rank #7 · DOI 10.1136/bmj.r1735
Archives of Disease in Childhood · 2026-01-19
Obesity, diabetes and glucagon-like peptide-1 receptor agonists
Phrase rank #8 · DOI 10.1136/archdischild-2025-330241
Gut · 2026-06-26
IDDF2026-ABS-0326 Glucagon-like peptide-1 receptor agonists are associated with reduced risk of opioid use and invasive interventions in chronic pancreatitis: a real-world cohort study
Phrase rank #9 · DOI 10.1136/gutjnl-2026-IDDF.312
Heart · 2026-06-09
54 Cardiovascular safety of glucagon-like peptide-1 receptor agonists in real-world practice: a comparative phenotype-based analysis
Phrase rank #9 · DOI 10.1136/heartjnl-2026-BCS.237
Journal of Scleroderma and Related Disorders · 2026-06-05
P.231 Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach
Phrase rank #9 · DOI 10.1136/JSRD-2026-SSWC.275
Journal for ImmunoTherapy of Cancer · 2026-01-29
Advancing ICOS agonism in solid tumors: lessons from INDUCE-1
Phrase rank #9 · DOI 10.1136/jitc-2025-013991
BMJ Supportive & Palliative Care · 2025-11-11
Orexin receptor antagonists for delirium prevention: systematic review in cancer
Phrase rank #9 · DOI 10.1136/spcare-2025-005892
Journal for ImmunoTherapy of Cancer · 2025-11-04
9 A novel humanized mouse model for assessing anti-tumor therapy with anti-human PD-1 and human IL12 bispecific antibody
Phrase rank #9 · DOI 10.1136/jitc-2025-SITC2025.0009
Journal for ImmunoTherapy of Cancer · 2025-11-04
847 The multabody: a next-generation approach for cancer immunotherapy and 4–1BB agonist therapy
Phrase rank #9 · DOI 10.1136/jitc-2025-SITC2025.0847
BMJ Case Reports · 2025-10-26
Anaesthetic management of a patient with a unique combination of anti-N-methyl-D-aspartate receptor encephalitis and stiff-person syndrome
Phrase rank #9 · DOI 10.1136/bcr-2017-223261
Journal of Scleroderma and Related Disorders · 2026-06-05
P.033 BAG3 as a possible therapeutic target and biomarker in systemic sclerosis
Phrase rank #10 · DOI 10.1136/JSRD-2026-SSWC.86
Journal for ImmunoTherapy of Cancer · 2026-03-30
HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering
Phrase rank #10 · DOI 10.1136/jitc-2025-014185
Heart · 2026-03-25
Managing glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in clinical practice
Phrase rank #10 · DOI 10.1136/heartjnl-2024-324847
Journal for ImmunoTherapy of Cancer · 2025-11-04
414 Estrogen receptor beta agonist OSU-ERβ-12 enhances αnti-PD1 efficacy in an immunotherapy resistant mouse model
Phrase rank #10 · DOI 10.1136/jitc-2025-SITC2025.0414
Thorax · 2025-11-02
P158 The association between GLP-1 receptor agonist use and mortality among COPD patients
Phrase rank #10 · DOI 10.1136/thorax-2025-BTSabstracts.339
Practical Neurology · 2025-09-12
Adult-onset Rasmussen’s encephalitis with anti-AMPA receptor antibodies
Phrase rank #10 · DOI 10.1136/pn-2025-004520
European Journal of Hospital Pharmacy · 2026-03-18
NP-009 Discontinuation and predictive factors in patients treated with GLP-1 receptor analogues: evidence from Sicilian distribution 'per conto' (DPC) data (2021-2024)
Phrase rank #11 · DOI 10.1136/ejhpharm-2026-eahp.9
Lupus Science & Medicine · 2026-03-01
PO:11:280 Randomized, placebo-controlled, double-blind phase 1b/2 study to explore safety, pharmacokinetics, and initial efficacy of DS-7011a, an anti-toll-like receptor 7 monoclonal antibody, in SLE patients
Phrase rank #11 · DOI 10.1136/lupus-2026-el.334